HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

International Conference On Orphan Drugs and Rare Diseases

August 21-23, 2023

August 21 -23, 2023 | London, UK

Drug Discovery and Developments

Drug Discovery and Developments

Pharmaceuticals used for the diagnosis, prevention, and treatment of rare diseases are known as orphan drugs. Rare diseases differ from common diseases in that they have a low prevalence rate and so appeal to a small patient population. These medications are being developed to treat people with extremely rare disorders for which there is now no therapy option. Pharmaceutical inventors are often discouraged from developing treatments for extremely limited patient groups due to the increasing expense of medication research in tandem with rigorous regulations, as well as the low return on investment. Orphan diseases are rare diseases that affect small patient groups and are consequently "orphaned" by the pharmaceutical industry, with only a few authorized pharmacological therapy choices available. Incentives for orphan drugs have sparked research into diseases with a high unmet medical need.

  • Clinical Insight
  • Drug Clinical Status
  • Global Market Opportunity
  • Orphan Clinical Pipeline
  • Drug Class & Formulation
Committee Members
Speaker at Orphan Drugs and Rare Diseases 2023 -  Daniel Scherman

Daniel Scherman

Fondation Maladies Rares, France
Speaker at Orphan Drugs and Rare Diseases 2023 -  Jiao Fuyong

Jiao Fuyong

Children’s Hospital of Shaanxi Provincial People’s Hospital, China
Speaker at Orphan Drugs and Rare Diseases 2023 -  Victor Shengkan jin

Victor Shengkan jin

Rutgers University, United States
Orphan Drugs 2023 Speakers
Speaker at Orphan Drugs and Rare Diseases 2023 - Candida Fratazzi

Candida Fratazzi

BBCR Consulting - Massachusetts, United States
Speaker at Orphan Drugs and Rare Diseases 2023 - Philip Bielefeld

Philip Bielefeld

Avignon Hospital, France
Speaker at Orphan Drugs and Rare Diseases 2023 - Harsha Rajasimha

Harsha Rajasimha

Jeeva Informatics Solutions Inc, United States

Submit your abstract Today

Watsapp